DJIA 17,151.17 176.86 1.04%
NASDAQ 4,564.51 15.28 0.34%
S&P 500 1,995.08 12.78 0.64%
market minute promo

Express Scripts (NASDAQ: ESRX)

75.63 1.60 (2.16%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ESRX $75.59 2.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $74.00
Previous Close $74.03
Daily Range $73.95 - $75.80
52-Week Range $61.66 - $79.37
Market Cap $55.5B
P/E Ratio 29.61
Dividend (Yield) $0.00 (0.0%)
Volume 2,986,961
Average Daily Volume 3,862,683
Current FY EPS $4.88

Sector

Healthcare

Industry

Healthcare Information Services

Express Scripts (ESRX) Description

Provides pharmacy benefit management services, including retail drug card programs, mail pharmacy services, drug formulary management programs and other clinical management programs for HMOs, health insurers, third-party administrators and employers. Website: http://www.express-scripts.com/

News & Commentary Rss Feed

Express Scripts' Struggles May Be Easing

Express Scripts' third-quarter results may suggest that the company is moving in the right direction back toward growth.

Express Scripts Reports In-Line Q3 Earnings, Narrows View - Analyst Blog

Express Scripts Holding's (ESRX) CEO George Paz on Q3 2014 Results - Earnings Call Transcript

Buybacks-Driven Market: Engineered Too Far?

#PreMarket Primer: Wednesday, October 29: Fed Likely To End Bond Purchases

Express Scripts Posts EPS In-line With Estimates

After-Hours Earnings Report for October 28, 2014 : FB, GILD, ESRX, MCK, APC, AFL, VRTX, EQR, AMP, W

After-Hours Earnings Report for October 28, 2014 : FB, GILD, ESRX, MCK, APC, AFL, VRTX, EQR, AMP, WDC, MAR, EIX

3 Health Services Stocks Pushing The Industry Higher

#PreMarket Primer: Tuesday, October 28: CDC Warns That Involuntary Quarantines Could Discourage Prog

#PreMarket Primer: Tuesday, October 28: CDC Warns That Involuntary Quarantines Could Discourage Progress On Ebola

Insuline: Significant Upside, Alternative Diabetes Play With A Population Based Cost-Reduction Platf

Insuline: Significant Upside, Alternative Diabetes Play With A Population Based Cost-Reduction Platform In Diabetes

See More ESRX News...

ESRX's Top Competitors

ESRX $75.63 (2.16%)
Current stock: ESRX
UNH $94.05 (1.17%)
Current stock: UNH
WLP $123.44 (1.01%)
Current stock: WLP
FMS $36.60 (0.91%)
Current stock: FMS